Ascendis Pharma A/S (ASND)
210.95
+2.19
(+1.05%)
USD |
NASDAQ |
Jan 13, 10:17
Ascendis Pharma Accounts Payable (Quarterly): 92.36M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Novo Nordisk A/S | 3.763B |
| Evaxion AS | -- |
| DBV Technologies SA | 39.82M |
| Cellectis SA | 16.10M |
| Biodexa Pharmaceuticals Plc | -- |